Transcelerate teams to take on investigator selection bias
A register of clinical investigators can help eliminate bias according to Big Pharma Group Transcelerate, which has teamed with DrugDev to develop such a database.
Archives for February 24, 2015
FTC requires Novartis to divest two potential cancer drugs to Array as part of GSK deal
In order to close Novartis’ $16bn purchase of GlaxoSmithKline’s portfolio of cancer treatments, the FTC (Federal Trade Commission) is requiring Novartis to divest all assets related to its potential BRAF and MEK inhibitor drugs to settle anticompetitive...
LabCorp to operate under two segments following $5.7bn Covance merger
The integration of Covance and LabCorp is beginning with the announcement that LabCorp will operate under two distinct segments: LabCorp Diagnostics and Covance Drug Development, LabCorp CEO Dave King said in a conference call last week.
Assembly line could cut cost of HIV drug API production say German researchers
The HIV drug API efaverinz could be made faster and more cheaply using continuous manufacturing according to the German team behind a new ‘assembly line’ production method.
Huntingdon to be renamed to mark Harlan integration
Huntingdon Life Sciences has announced it will change its name this year, but has not disclosed what its new moniker will be. So Outsourcing-pharma.com would welcome readers’ suggestions.
Catalent wants to raise $630m through follow on offering
Catalent wants to raise $629.3m (EUR550m) through a follow-on offering that will see Blackstone sell 17.6m shares.